MACS provides support to Maryland prescribers and their practices in addressing the needs of their patients with substance use disorders and chronic pain management.
The Maryland Addiction Consultation Service for Maternal Opioid Misuse (MACS for MOMs) supports maternal health providersin addressing the needs of their pregnant and postpartum patients with substance use disorders, particularly opioid use disorder.
MACS for MOMs, an expansion of the Maryland Addiction Consultation Service (MACS), is a statewide program funded by the Maryland Department of Health and the Centers for Medicare and Medicaid Services.
With support and guidance from MACS' team of expert addiction and maternal health specialists, prescribers have access to:
Consultation: clinical questions, resources, and referral information
Training: Continuing education credit and ongoing support
TeleECHO Clinic: Real-time, online learning sessions with expert specialist teams
Save Lives Now: Overdose Deaths Have Increased During COVID-19
As the overdose epidemic continues to evolve, expand, and accelerate, urgent actions for innovative strategies within the public health community are required to facilitate continued access to treatment. Read more...
LGBTQ-Affirmative Behavioral Health Services in Primary Care
Evidence-based specialty behavioral health treatments can be tailored to meet the needs of LGBTQIA+ patients more adequately while also adhering to the brief, structured primary care behavioral health model. Read more...
Addiction Should Be Treated, Not Penalized
Abundant data show that Black people and other communities of color have been disproportionately harmed by decades of addressing drug use as a crime rather than as a matter of public health.Read more...
Substance use predictors of attendance among veterans in integrated PTSD and alcohol use disorder treatment
This study examined substance use–related predictors of session attendance among veterans randomized to receive integrated exposure therapy or integrated coping skills therapy in a clinical trial for comorbid PTSD+AUD.Read more...
Screen of drug use: Diagnostic accuracy for stimulant use disorder
From 2015 to 2016, mortality rates involving cocaine and psychostimulants were smaller than opioids, but were rising faster than opioids. This research examined individual substances listed on death certificates to better understand stimulant-associated mortality and assess rates over time. Read more...
Putting it into practice: Register for our upcoming webinaron stimulant use disorders.
HOLIDAYS | The MACS line will be closed:
Friday, June 18 - Juneteenth
#MACSpotlight - May
Get to know the MACS team!
Each month we will feature a MACS team member in the #MACSpotlight.
Follow us on social media for the next #MACSpotlight on Friday, 6/18.
